Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 350Polycystic Ovary Syndrome 39Endometrial Neoplasms 22Neoplasm Metastasis 21Ovarian Neoplasms 16Infertility 12Neoplasms 11Fallopian Tube Neoplasms 8Advanced Breast Cancer 8Triple Negative Breast Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Carcinoma, Ductal, Breast 7Breast Neoplasms, Male 7Recurrence 6Osteoporosis 6Carcinoma, Lobular 6Breast Diseases 6Breast Carcinoma In Situ 6Prostatic Neoplasms 5Leiomyoma 4Infertility, Female 4Hereditary Sensory and Autonomic Neuropathies 4Breast Cancer Metastatic 4Neoplasms, Hormone-Dependent 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Anovulation 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Interventions

Methotrexate 6Dactinomycin 6camrelizumab 3Drug Therapy 3toripalimab 2pembrolizumab 2apatinib 2Vacuum Curettage 2Psychiatric Rehabilitation 2Methylprednisolone 2Leucovorin 2Filgrastim 2Etoposide 2Cyclophosphamide 2Carboplatin 2Alemtuzumab 2zimberelimab 1sargramostim 1dostarlimab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carotuximab 1aldesleukin 1Vincristine 1Thrombopoietin 1Tacrolimus 1Surgical Procedures, Operative 1Specimen Handling 1Prednisone 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gestational Trophoblastic Disease × Letrozole × Clear all
NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown
200 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡